What are the recommended medications for backache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Medications for Backache

First-Line Treatment: NSAIDs and Acetaminophen

For both acute and chronic low back pain, NSAIDs are the most strongly recommended first-line pharmacological treatment, with good evidence demonstrating moderate pain relief (10-20 points on a 100-point scale). 1

NSAIDs (Preferred First-Line)

  • NSAIDs like ibuprofen show superior efficacy to placebo for global improvement (RR 1.24) and reduced need for additional analgesics (RR 1.29) after 1 week of therapy in acute low back pain. 1
  • For chronic low back pain, ibuprofen demonstrates effectiveness superior to placebo in high-quality trials. 1
  • No specific NSAID has proven superior to others for pain relief, so choose based on cost and patient-specific risk factors. 1
  • Use NSAIDs at the lowest effective dose for the shortest duration necessary due to risks of gastrointestinal bleeding, cardiovascular events, and renal complications. 2, 3
  • In elderly patients, carefully assess cardiovascular, gastrointestinal, and renal risk factors before prescribing NSAIDs. 2

Acetaminophen (Alternative First-Line)

  • Acetaminophen up to 4g/24 hours is recommended as first-line treatment, particularly in elderly patients, due to its favorable safety profile. 2
  • Evidence shows acetaminophen is slightly inferior to NSAIDs for pain relief (standardized mean difference ~0.3), but the difference is modest. 1
  • Monitor for hepatotoxicity, especially at maximum doses. 2
  • For acute low back pain, no significant difference exists between acetaminophen (3g/day) and no treatment in one trial. 1

Second-Line Treatment: Skeletal Muscle Relaxants

For acute low back pain requiring additional relief beyond NSAIDs, skeletal muscle relaxants are effective for short-term pain relief, with good supporting evidence. 1

Cyclobenzaprine (Preferred Muscle Relaxant)

  • Cyclobenzaprine 5mg three times daily demonstrates statistically significant superiority over placebo for pain relief, global improvement, and medication helpfulness at day 8. 4
  • Start with 5mg doses in elderly patients and those with hepatic impairment, titrating slowly upward. 4
  • Common side effects include drowsiness and dry mouth; use time-limited courses due to sedation risk. 4
  • Cyclobenzaprine produces clinical improvement whether or not sedation occurs. 4

Tizanidine (Alternative Muscle Relaxant)

  • Tizanidine is considered more effective than baclofen for lumbar radiculopathy with a better safety profile. 5
  • The American College of Physicians does not recommend baclofen as a preferred muscle relaxant option. 5

Third-Line Treatment: Tricyclic Antidepressants for Chronic Pain

For chronic low back pain, tricyclic antidepressants show small to moderate effects for pain relief (effect size 0.5-0.8). 1, 5

  • Tricyclic antidepressants have good evidence for effectiveness specifically in chronic (not acute) low back pain. 1
  • The magnitude of benefit is smaller than NSAIDs or muscle relaxants but may be appropriate for patients with concurrent depression. 1

Specialized Treatment: Gabapentin for Radiculopathy

For low back pain with radiculopathy (sciatica), gabapentin demonstrates small, short-term benefits specifically for radicular symptoms. 1, 5

  • Gabapentin has fair evidence for effectiveness in patients with nerve root involvement. 1
  • Consider gabapentin when radicular symptoms predominate over axial back pain. 5

Fourth-Line Treatment: Opioids (Use Judiciously)

Opioid analgesics or tramadol may be considered only for severe, disabling pain not controlled with acetaminophen and NSAIDs, with careful weighing of substantial risks including abuse potential. 2

  • Prescribe opioids only for breakthrough pain, at the lowest effective dose, for the shortest period. 2
  • Combination hydrocodone/ibuprofen and oxycodone/acetaminophen show similar efficacy and tolerability for moderate to severe acute low back pain. 6
  • Opioids are not first-line due to abuse potential despite being more potent analgesics. 7

Treatments NOT Recommended

Systemic corticosteroids have good evidence of ineffectiveness for low back pain with or without sciatica and should not be used. 1, 5

  • Baclofen is not recommended as a preferred muscle relaxant option. 5
  • Bed rest is ineffective based on low-quality evidence. 8

Treatment Algorithm

  1. Start with NSAIDs (ibuprofen 200-400mg every 4-6 hours, max 5 tablets/day) or acetaminophen (up to 4g/24 hours) for all patients with acute or chronic low back pain. 1, 2, 3

  2. If inadequate relief after 3-7 days, add cyclobenzaprine 5mg three times daily for acute low back pain (time-limited course). 5, 4

  3. For chronic low back pain not responding to NSAIDs alone, consider tricyclic antidepressants rather than adding muscle relaxants. 1, 5

  4. For radiculopathy symptoms (leg pain, numbness, tingling), add gabapentin to the regimen. 1, 5

  5. Reserve opioids only for severe, disabling pain unresponsive to the above measures, using the shortest duration and lowest dose. 2

Critical Pitfalls to Avoid

  • Never prescribe systemic corticosteroids for low back pain—they are proven ineffective. 1, 5
  • Avoid long-term muscle relaxant use; prescribe for fixed, time-limited periods only due to sedation and limited long-term safety data. 5
  • Do not use baclofen when tizanidine or cyclobenzaprine are available. 5
  • In elderly patients, avoid starting NSAIDs without assessing cardiovascular, renal, and gastrointestinal risk factors. 2
  • Most trials evaluate only short-term therapy (≤4 weeks); reliable data on long-term benefits and harms are sparse. 1
  • Combination therapy data are limited; most evidence supports monotherapy with sequential additions if needed. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.